According to our research report, the size of the Asia Pacific Biopsy Devices Market was worth USD 349.30 million in 2022 and is estimated to be growing at a CAGR of 8.54% to reach USD 526.20 million by 2027.
A biopsy is a medical examination performed by surgeons, radiologists, or cardiologists to extract sample cells or tissues to detect disease. The tissue is usually studied by pathologists under a microscope or may be analyzed by chemical examination. The most effective method of detecting cancer and inflammatory disorders is to conduct biopsies. A biopsy involves the removal of cells or tissues from tumors located in different parts of the body, and the devices used for this process are called biopsy devices. The market is regarded as rapid innovation and technological developments, leading to continuous product improvement ensuring better patient comfort and minor trauma during and after surgery.
The Asia Pacific is estimated to represent strong potential market growth in the biopsy devices market due to fast technological advancements. Increasing incidences of cancer, increasing demand for minor invasive surgeries, and government support and initiatives in the region are the leading causes of the growth of the biopsy devices market. In addition, increased public awareness of the need for early disease detection and improved product designs are also driving the growth of the biopsy devices market in the Asia Pacific. Although the research in biopsy diagnostics is not as advanced as in Western countries, it is still growing faster than its western counterparts. Hence, more funding is being received for cancer diagnostic research.
The market is anticipated to record growth mostly because of the quickly aging population and a parallel increase in cancer incidence. In addition, competitive pricing of products and reimbursement for biopsy procedures will lead to a higher uptake of biopsy devices, thereby driving the market's growth.
The high cost of biopsy devices is likely to hamper the growth of the market. High prices of these cutting-edge instruments are a deterrent in price-sensitive markets such as South East Asia. In addition, product recalls due to a rising number of quality and accuracy issues have hindered the growth of this market. Recently Asia-Pacific region is witnessing a massive challenge in the form of the growing COVID-19 cases, which has adversely influenced even cancer diagnostics. Cancer patients are faced with tremendous diagnosis and treatment issues, and progress tests are delayed as hospitals struggle with rising COVID-19 cases.
This research report on the Asia-Pacific Biopsy Devices Market has been segmented & sub-segmented into the following categories:
By End User:
Regionally, the Asia Pacific region is the third-largest market share by region after North America and Europe. However, it is also the fastest-growing region in the world. Reforms introduced in India and China are poised to increase their purchasing power, further escalating the market's growth. China is the biggest name in this region, followed closely by Japan and India. Japan has a better healthcare infrastructure conducive to research, but India is the fastest-growing market due to the sheer size of the diseased population.
One recent factor that may significantly shift the region's landscape is the anti-China sentiment in countries, especially in India. With the Indian government's increased efforts to make everything in-house, the upcoming few years would be the one to watch out for as other countries’ dependence on China is likely to lessen, with India being an obvious alternative. South Korea and Australia are the other notable countries in the market.
The Chinese biopsy devices market is dominating the Asia Pacific. The Indian biopsy devices market is estimated to grow at the highest CAGR in the forecast period due to the rising aging population.
KEY MARKET PLAYERS:
A few of the companies playing a key role in the APAC Biopsy Devices Market profiled in this report are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2.2 Needle Biopsy
220.127.116.11 Core Needle Biopsy
18.104.22.168 Fine Needle Biopsy
22.214.171.124 Vacuum-Assisted Biopsy
5.2.3 Surgical Biopsy
126.96.36.199 Incisional Biopsy
188.8.131.52 Excisional Biopsy
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3.2 Scientific Research
5.3.3 Medical Diagnosis
5.3.4 Agricultural Applications
5.3.5 Genetic fingerprinting & Sex Determination
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End Users
5.4.2 Pharmaceutical and Biotechnology Industry
5.4.3 Academic Research Institute
5.4.4 Contract Research Organizations
5.4.5 Forensic Labs
5.4.6 Y-o-Y Growth Analysis, By End Users
5.4.7 Market Attractiveness Analysis, By End Users
5.4.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Type
22.214.171.124 By Application
126.96.36.199 By End User
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Type
18.104.22.168 By Application
22.214.171.124 By End User
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Type
220.127.116.11 By Application
18.104.22.168 By End User
6.5 South Korea
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Leica Biosystems
8.3 Hologic Inc.
8.4 Boston Scientific Corporation
8.6 Cook Medical Inc.
8.7 C.R. Bard Inc.
8.8 Mauna Kea Technologies
8.9 Ethicon EndoSurgery Inc.
8.10 Veran Medical Technologies
8.11 Dickinson and Company
8.12 Fujifilm Medical Systems
8.14 Argon Medical Devices Inc
8.15 Intact Medical Corp
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.